Skip to main content

Market Overview

Freeport-McMoRan, AppLovin And A Major Healthcare Stock On CNBC's 'Final Trades'

Share:
Freeport-McMoRan, AppLovin And A Major Healthcare Stock On CNBC's 'Final Trades'

On CNBC’s "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management said AppLovin Corporation (NASDAQ: APP) is the number one performing large cap stock of the year so far.

On April 16, Morgan Stanley analyst Matthew Cost maintained AppLovin with an Equal-Weight rating and raised the price target from $55 to $70.

Stephanie Link of Hightower said she likes Freeport-McMoRan Inc. (NYSE: FCX) amid recovery in China.

On April 9, BofA Securities analyst Lawson Winder upgraded Freeport-McMoRan from Neutral to Buy and announced a $59 price target, while Scotiabank analyst Orest Wowkodaw maintained the stock with a Sector Outperform and raised the price target from $48 to $55.

Freeport-McMoRan is a top holding in the broader SPDR S&P Metals & Mining ETF (ARCA: XME).

Don’t forget to check out our premarket coverage here

Jim Lebenthal of Cerity Partners named CVS Health Corporation (NYSE: CVS), which is set to report quarterly earnings soon.

CVS Health is scheduled to hold a conference call with analysts and investors on May 1 to discuss first quarter 2024 financial results. Analysts expect the company to report quarterly earnings at $1.71 per share, down from $2.2 per share in the year-ago period. The company is projected to post quarterly revenue of $89.21 billion, up from $80.81 billion in the year-earlier quarter.

Price Action:

  • AppLovin shares rose 1.3% to close at $72.32 on Tuesday.
  • Freeport-McMoRan shares fell 1.2% to settle at $49.41 on Tuesday.
  • CVS Health shares rose 0.1% to close at $69.03 during Tuesday’s session.

Check This Out: Abbott Laboratories, U.S. Bancorp And 3 Stocks To Watch Heading Into Wednesday

 

Related Articles (APP + CVS)

View Comments and Join the Discussion!

Posted-In: CNBC Halftime Report Final TradesLong Ideas News Top Stories Markets Media Trading Ideas Best of Benzinga

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com